|
🐜
|
Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy.
7 auth.
F. Stocchi,
A. Carbone,
Maurizio Inghilleri,
A. Monge,
S. Ruggieri,
A. Berardelli,
...
M. Manfredi
|
7 |
1997 |
7
🐜
|
|
🐜
|
Apomorphine and lisuride infusion. A comparative chronic study.
7 auth.
F. Stocchi,
L. Bramante,
A. Monge,
F. Viselli,
F. Baronti,
E. Stefano,
...
S. Ruggieri
|
6 |
1993 |
6
🐜
|
|
🐜
|
The long-duration action of levodopa may be due to a postsynaptic effect.
7 auth.
L. Barbato,
F. Stocchi,
A. Monge,
L. Vacca,
Stefano Ruggieri,
G. Nordera,
...
C. Marsden
|
5 |
1997 |
5
🐜
|
|
🐬
|
Melperone in the treatment of iatrogenic psychosis in Parkinson's disease.
L. Barbato,
A. Monge,
F. Stocchi,
G. Nordera
|
5 |
1996 |
5
🐬
|
|
🐜
|
Apomorphine Infusion and the Long-Duration Response to Levodopa in Advanced Parkinson's Disease
7 auth.
F. Stocchi,
A. Berardelli,
L. Vacca,
L. Barbato,
A. Monge,
G. Nordera,
...
S. Ruggieri
|
4 |
2003 |
4
🐜
|
|
🦁
|
Variation in the Dopaminergic Response During the Day in Parkinson Disease
9 auth.
A. Monge,
F. Viselli,
F. Stocchi,
L. Barbato,
A. Bolner,
N. Modugno,
...
M. Paradiso,
S. Ruggieri,
G. Nordera
|
4 |
2004 |
4
🦁
|
|
🐬
|
Determination of apomorphine in human plasma by alumina extraction and high-performance liquid chromatography with electrochemical detection.
A. Bolner,
L. Barbato,
F. Tagliaro,
A. Monge,
F. Stocchi,
G. Nordera
|
3 |
1997 |
3
🐬
|
|
🐬
|
Interleukin-10 pharmacokinetics in intact and nephrectomized mice.
P. Chiu,
E. Radwanski,
G. Tetiloff,
A. Monge,
S. J. Swanson
|
3 |
1996 |
3
🐬
|
